Ingredients	Processing	Packaging	Market Trends
Regulatory	Interview	Food Safety	Instrumentation

Change text size [+] [-]

Danisco sells part of Genencor's health care product portfolio

2 November 2005

Email This |

Printer Friendly

Danisco is selling part of Genencor's Health Care activities to Cambridge Antibody Technology (CAT) for $14 million. On closing, Danisco will hold $14 million in shares in CAT subscribed at market price. The CAT shares that Danisco will receive are free of any restrictions. The transaction is expected to close on 4 November 2005.

www.danisco.com/cms/connect/corporate/media+relations/news/frontpage/investor_182_en.htm